A Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses and Effect of Food on the Pharmacokinetics of DM1157 in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 19 Nov 2019
Price : $35 *
At a glance
- Drugs DM-1157 (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man; Pharmacokinetics
- 14 Nov 2019 Status changed from suspended to discontinued.
- 13 Jun 2019 Planned End Date changed from 4 Jun 2019 to 4 Sep 2019.
- 13 Jun 2019 Planned primary completion date changed from 4 Jun 2019 to 4 Sep 2019.